Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ajsn6c
    Junior Member
    • Oct 2015
    • 7

    #1

    ChIP-seq and Peak calling

    I have a simple question that I would like some opinions on. If a transcription factor is highly expressed (protein) in one cell and say now that the expression of is halved because of knock down experiment and you do ChIP-seq on both conditions, would you expect a similar amount peaks found using MACS, or rather a lower level of signal intensity in the knock down condition. I would think just a lower signal, but I'm curious what you all think

    Thanks!
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    My guess is that some peaks would be largely unaffected while others would vanish completely. This is mostly because I would guess that in some regions the factor would be more heavily recruited and/or bind with higher affinity, thereby sponging up the available supply. Of course, one could also envisage a scenario wherein signal intensity is roughly halved globally (of course, scaling might screw this up), or decreased even further (e.g., if binding can only occur as dimers and the probability of dimerization is now lower).

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
      by SEQadmin2



      CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

      Despite this, “CRISPR helped turn genome editing from a specialized technique into
      ...
      07-31-2026, 11:01 AM
    • SEQadmin2
      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
      by SEQadmin2


      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

      The systematic characterization of the human proteome has
      ...
      07-20-2026, 11:48 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 08-06-2026, 07:41 AM
    0 responses
    23 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 08-03-2026, 10:13 AM
    0 responses
    39 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-31-2026, 02:55 AM
    0 responses
    43 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 07-24-2026, 12:17 PM
    0 responses
    27 views
    0 reactions
    Last Post SEQadmin2  
    Working...